Circulating tumour cell analysis to predict efficacy of Eribulin for metastatic breast cancer patients

被引:0
|
作者
Horimoto, Yoshiya [1 ]
Murakami, Fumi [1 ]
Saito, Mitsue [1 ]
机构
[1] Juntendo Univ, Sch Med, Dept Breast Oncol, Tokyo, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
E-2072
引用
收藏
页码:664 / 664
页数:1
相关论文
共 50 条
  • [21] Circulating TGFa and TNFa in metastatic breast cancer patients treated with eribulin. The TRANSERI project
    Garrone, Ornella
    Lo Nigro, Cristiana
    Michelotti, Andrea
    Montemurro, Fillippo
    Vandone, Anna Maria
    Abbona, Andrea
    Paccagnella, Matteo
    Falletta, Antonella
    Genua, Elena
    De Angelis, Claudia
    Tonissi, Federica
    Vanella, Paola
    CANCER RESEARCH, 2019, 79 (13)
  • [22] Practical experiences with eribulin in patients with metastatic breast cancer
    Tesch, Hans
    Schneeweiss, Andreas
    ANTI-CANCER DRUGS, 2016, 27 (02) : 112 - 117
  • [23] Eribulin patients with metastatic breast cancer in clinical practice
    Poggio, F.
    Lambertini, M. L. Matteo
    D'Alonzo, A. D. Alessia
    Levaggi, A. L. Alessia
    Giraudi, S. G. Sara
    Bighin, C. B. Claudia
    Iacono, G. I. Giuseppina
    Pronzato, P. P. Paolo
    Del Mastro, L. D. M. Lucia
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S183 - S183
  • [24] Retrospective analysis of the efficacy and safety of eribulin therapy for metastatic breast cancer in daily practice
    Tanaka, Toshihiro
    Ueno, Miho
    Nakashima, Yuta
    Chinen, Shotaro
    Sato, Eiichi
    Masaki, Michio
    Mogi, Ai
    Sasaki, Hidenori
    Tamura, Kazuo
    Takamatsu, Yasushi
    THORACIC CANCER, 2017, 8 (05) : 523 - 529
  • [25] Landscape of circulating tumour DNA in metastatic breast cancer
    Davis, Andrew A.
    Jacob, Saya
    Gerratana, Lorenzo
    Shah, Ami N.
    Wehbe, Firas
    Katam, Neelima
    Zhang, Qiang
    Flaum, Lisa
    Siziopikou, Kalliopi P.
    Platanias, Leonidas C.
    Gradishar, William J.
    Behdad, Amir
    Cristofanilli, Massimo
    EBIOMEDICINE, 2020, 58
  • [26] Isolation of circulating tumour cells in patients with metastatic breast cancer by filter technology
    Elst, H.
    Van Der Auwera, I
    Vermeulen, P.
    Prove, A.
    Van Dam, P.
    Huget, P.
    Dirix, L.
    CANCER RESEARCH, 2009, 69 (02) : 308S - 309S
  • [27] Eribulin for the treatment of metastatic breast cancer: an update on its safety and efficacy
    Doherty, Mark K.
    Morris, Patrick G.
    INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2015, 7 : 47 - 58
  • [28] Circulating tumor cell levels can predict survival in metastatic breast cancer
    Nature Clinical Practice Oncology, 2006, 3 (10): : 527 - 527
  • [29] Efficacy of eribulin in patients with metastatic breast cancer with brain metastases in routine practice in Russian Federation
    Kolyadina, I.
    Bulavina, I.
    Petkau, V.
    Gorbunova, V.
    Zhukova, L.
    Ganshina, I.
    Ponomarenko, D.
    Shikina, V.
    Popova, N.
    Golberg, V.
    BREAST, 2019, 44 : S62 - S62
  • [30] Eribulin efficacy for metastatic breast cancer amongst the realworld treatment pattern
    Kojima, Yasuyuki
    Tsugawa, Koichiro
    ANNALS OF ONCOLOGY, 2017, 28 : 96 - 96